RAMAZZOTTI DANIELE

Cadamuro, F., Piazzoni, M., Borghi, I., Baeri, A., Fumagalli, A., Perillo, F., et al. (2026). 3D Bioprinted Glioblastoma Multiforme Models: How the Extracellular Matrix Glycosignature Influences Drug Response. ADVANCED FUNCTIONAL MATERIALS [10.1002/adfm.77772]. Dettaglio

Ghizzi, M., Sinoni, E., Redaelli, S., Sirtori, A., Ramazzotti, D., Cazzaniga, G., et al. (2026). Integrated characterization of EGFR amplification architecture and EGFRvIII status in patient-derived glioblastoma stem cells. Intervento presentato a: XXIX Congresso Nazionale SIGU - 7-9 ottobre 2026, Rimini, Italia. Dettaglio

Civettini, I., Malighetti, F., Villa, M., Crippa, V., Aroldi, A., Cavalca, F., et al. (2026). Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution. NEJM EVIDENCE, 5(6), 1-13 [10.1056/evidoa2500124]. Dettaglio

Buscaroli, E., Sadr, A., Bergamin, R., Milite, S., Villegas Garcia, E., Tasciotti, A., et al. (2026). BASCULE: bayesian inference and clustering of mutational signatures leveraging biological priors. GENOME BIOLOGY, 27(1) [10.1186/s13059-025-03835-9]. Dettaglio

Malighetti, F., Civettini, I., Aroldi, A., Villa, A., Villa, M., Sala, L., et al. (2026). Liquid biopsies reveal dual compartments of cancer risk from tumor and host-derived mutations. BIOINFORMATICS, 42(Supplement_2) [10.1093/bioinformatics/btag491]. Dettaglio